NDAINTRAVENOUSSOLUTIONPriority Review
Approved
Jun 2009
Lifecycle
Peak
Competitive Pressure
0/100
Clinical Trials
20
Data completeness
5/8 — Partial
Priority Review
CALDOLOR (ibuprofen) by Cumberland Pharmaceuticals is cyclooxygenase inhibitors [moa]. First approved in 2009.
Drug data last refreshed 8h ago · AI intelligence enriched 5d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
CALDOLOR (ibuprofen) is an intravenous nonsteroidal anti-inflammatory drug (NSAID) approved in 2009 for fever and pain management in hospitalized patients. It works by inhibiting cyclooxygenase enzymes to reduce inflammation and provide rapid symptomatic relief. The IV formulation offers an alternative to oral NSAIDs in acute care settings where oral administration is not feasible.
Peak5.5 years to LOE
Product is in peak lifecycle stage with established market presence; team focus likely on maintaining share in hospital formularies and optimizing reimbursement rates.
Mechanism of Action
Cyclooxygenase Inhibitors
Pharmacologic Class:
Nonsteroidal Anti-inflammatory Drug
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (20)
A Comparative Bioavailability Study of Reformulated Ibuprofen 2% and 4% Oral Suspensions (Berlin Chemie AG) and Versus Ibuprofen (Nurofen®) 200 mg/5 ml Oral Suspension
Started Nov 2023
74 enrolled
Healthy Male and Female Subjects
Efficacy and Safety of S (+) - Ibuprofen in Osteoarthritis Pain
Started Aug 2022
176 enrolled
Osteoarthritis
Efficacy and Safety of S (+) - Ibuprofen in the Treatment of Mechanical Low Back Pain
Started Jun 2022
177 enrolled
Low Back Pain, MechanicalLow Back PainAcute Low Back Pain
Postoperative Analgesic Effects of Ibuprofen Versus Ketorolac in Patients Undergoing in Orthopedic Surgery
Started Aug 2021
100 enrolled
Intravenous Drug UsageIbuprofenKetorolac+2 more
Ibuprofen Plus Acetaminophen for Enhanced Pain Reduction
Started Mar 2021
Worked on CALDOLOR at Cumberland Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.